Musculoskeletal Complications of Fluoroquinolones: Guidelines and Precautions for Usage in the Athletic Population

PM and R

Volumn 3, Issue 2, 2011, Pages 132-142

  Hall, Mederic M ^a   Finnoff, Jonathan T ^b   Smith, Jay ^b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CIPROFLOXACIN; CORTICOSTEROID; DEXAMETHASONE; ENROFLOXACIN; GATIFLOXACIN; GEMIFLOXACIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOFLOXACIN; MAGNESIUM; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOCOPHEROL; TRIAMCINOLONE; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTHRALGIA; ARTICLE; ATHLETE; BONE; CARTILAGE; CARTILAGE INJURY; CHONDROPATHY; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; FRACTURE HEALING; HUMAN; METABOLIC PARAMETERS; MUSCLE; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; MYALGIA; MYOPATHY; NONHUMAN; PAIN; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHABDOMYOLYSIS; RISK FACTOR; SIDE EFFECT; TENDINITIS; TENDON; TENDON RUPTURE; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BONE AND BONES; CARTILAGE; FLUOROQUINOLONES; HUMANS; MUSCLE, SKELETAL; MUSCULOSKELETAL SYSTEM; TENDINOPATHY; TENDONS;

EID: 79951664846     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2010.10.003     Document Type: Article

References (99)

1. Gürbay A., Garrel C., Osman M., Richard M.J., Favier A., Hincal F. Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E. Hum Exp Toxicol 2002, 21:635-641.
2. Holtom P.D., Pavkovic S.A., Bravos P.D., Patzakis M.J., Shepherd L.E., Frenkel B. Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. J Orthop Res 2000, 18:721-727.
3. Khaliq Y., Zhanel G.G. Musculoskeletal injury associated with fluoroquinolone antibiotics. Clin Plast Surg 2005, 32:495-502.
4. van der Linden P.D., van Puijenbroek E.P., Feenstra J., et al. Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum 2001, 45:235-239.
5. Mehlhorn A.J., Brown D.A. Safety concerns with fluoroquinolones. Ann Pharmacother 2007, 41:1859-1866.
6. Linder J.A., Huang E.S., Steinman M.A., Gonzales R., Stafford R.S. Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med 2005, 118:259-268.
7. Bailey R.R., Kirk J.A., Peddie B.A. Norfloxacin-induced rheumatic disease. N Z Med J 1983, 96:590.
8. Tanne J.H. FDA adds "black box" warning label to fluoroquinolone antibiotics. BMJ 2008, 337:a816.
9. Facts & Comparisons. Quinolones Accessed May 18, 2010. http://online.factsandcomparisons.com/MonoDisp.aspx?monoid=fandc-hcp14709%26book=DFC.
10. Facts & Comparisons. Fluoroquinolones Accessed May 18, 2010. http://online.factsandcomparisons.com/MonoDisp.aspx?monoID=fandc-hcp10874%26quick=374701%7c3%26search=374701%7c3%26isstemmed=true.
11. Movin T., Gad A., Güntner P., Földhazy Z., Rolf C. Pathology of the Achilles tendon in association with ciprofloxacin treatment. Foot Ankle Int 1997, 18:297-299.
12. Corps AN, Harrall RL, Curry VA, Fenwick SA, Hazleman BL, Riley GP. Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum 200;46:3034-3040.
13. Cebrian P., Manjon P., Caba P. Ultrasonography of non-traumatic rupture of the Achilles tendon secondary to levofloxacin. Foot Ankle Int 2003, 24:122-124.
14. Williams R.J., Attia E., Wickiewicz T.L., Hannafin J.A. The Effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am J Sports Med 2000, 28:364-369.
15. Boppart M.D., Volker S.E., Alexander N., Burkin D.J., Kaufman S.J. Exercise promotes alpha7 integrin gene transcription and protection of skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2008, 295:R1623-R1630.
16. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
17. Shakibaei M., de Souza P., van Sickle D., Stahlmann R. Biochemical changes in Achilles tendon from juvenile dogs after treatment with ciprofloxacin or feeding a magnesium-deficient diet. Arch Toxicol 2001, 75:369-374.
18. Sendzik J., Shakibaei M., Schäfer-Korting M., Stahlmann R. Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology 2005, 212:24-36.
19. Ireland D., Harrall R., Curry V., et al. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol 2001, 20:159-169.
20. Jain A., Brennan F., Nanchahal J. Treatment of rheumatoid tenosynovitis with cytokine inhibitors. Lancet 2002, 360:1565-1566.
21. Pouzaud F., Bernard-Beaubois K., Thevenin M., Warnet J.M., Hayem G., Rat P. In vitro discrimination of fluoroquinolones toxicity on tendon cells: involvement of oxidative stress. J Pharmacol Exp Ther 2004, 308:394-402.
22. Lowes D.A., Wallace C., Murphy M.P., Webster N.R., Galley H.F. The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells. Free Radic Res 2009, 43:323-328.
23. Gurbay A., Hincal F. Ciprofloxacin-induced glutathione redox status alterations in rat tissues. Drug Chem Toxicol 2004, 27:233-242.
24. Gürbay A., Gonthier B., Barret L., Favier A., Hincal F. Cytotoxic effect of ciprofloxacin in primary culture of rat astrocytes and protection by vitamin E. Toxicology 2007, 229:54-61.
25. Pfister K., Mazur D., Vormann J., Stahlmann R. Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats. Antimicrob Agents Chemother 2007, 51:1022-1027.
26. Bernard-Beaubois K., Hecquet C., Hayem G., Rat P., Adolphe M. In vitro study of cytotoxicity of quinolones on rabbit tenocytes. Cell Biol Toxicol 1998, 14:283-292.
27. Muzi F., Gravante G., Tati E., Tati G. Fluoroquinolones-induced tendinitis and tendon rupture in kidney transplant recipients: 2 cases and a review of the literature. Transplant Proc 2007, 39:1673-1675.
28. Damuth E., Heidelbaugh J., Malani P.N., Cinti S.K. An elderly patient with fluoroquinolone-associated Achilles tendinitis. Am J Geriatr Pharmacother 2008, 6:264-268.
29. Senneville E., Poissy J., Legout L., et al. Safety of prolonged high-dose levofloxacin therapy for bone infections. J Chemother 2007, 19:688-693.
30. Akali A.U., Niranjan N.S. Management of bilateral Achilles tendon rupture associated with ciprofloxacin: a review and case presentation. J Plast Reconstr Aesthet Surg 2008, 61:830-834.
31. Parmar C., Meda K.P. Achilles tendon rupture associated with combination therapy of levofloxacin and steroid in four patients and a review of the literature. Foot Ankle Int 2007, 28:1287-1289.
32. Ramirez M.A., Richardson L.C. Pulmonary embolism associated with spontaneous bilateral Achilles tendon rupture. J Foot Ankle Surg 2007, 46:283-287.
33. Vyas H., Krishnaswamy G. Images in clinical medicine. Quinolone-associated rupture of the Achilles' tendon. N Engl J Med 2007, 357:2067.
34. Sode J., Obel N., Hallas J., Lassen A. Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study. Eur J Clin Pharmacol 2007, 63:499-503.
35. Palin S.L., Gough S.C. Rupture of the Achilles tendon associated with ciprofloxacin. Diabet Med 2006, 23:1386-1387.
36. Shortt P., Wilson R., Erskine I. Tendinitis: the Achilles heel of quinolones!. Emerg Med J 2006, 23:e63.
37. Corrao G., Zambon A., Bertù L., et al. Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study. Drug Saf 2006, 29:889-896.
38. Luthje P., Nurmi I., Nyyssonen T. Missed Achilles tendon rupture due to oral levofloxacin: surgical treatment and result. Arch Orthop Trauma Surg 2005, 125:124-126.
39. McKinley B.T., Oglesby R.J. A 57-year-old male retired colonel with acute ankle swelling. Mil Med 2004, 169:254-256.
40. Burkhardt O., Köhnlein T., Pap T., Welte T. Recurrent tendinitis after treatment with two different fluoroquinolones. Scand J Infect Dis 2004, 36:315-316.
41. Braun D., Petitpain N., Cosserat F., et al. Rupture of multiple tendons after levofloxacin therapy. Joint Bone Spine 2004, 71:586-587.
42. Melhus A., Apelqvist J., Larsson J., Eneroth M. Levofloxacin-associated Achilles tendon rupture and tendinopathy. Scand J Infect Dis 2003, 35:768-770.
43. Schindler C., Pittrow D., Kirch W. Reoccurrence of levofloxacin-induced tendinitis by phenoxymethylpenicillin therapy after 6 months: a rare complication of fluoroquinolone therapy?. Chemotherapy 2003, 49:90-91.
44. Haddow L.J., Chandra Sekhar M., Hajela V., Gopal Rao G. Spontaneous Achilles tendon rupture in patients treated with levofloxacin. J Antimicrob Chemother 2003, 51:747-748.
45. Gold L., Igra H. Levofloxacin-induced tendon rupture: a case report and review of the literature. J Am Board Fam Pract 2003, 16:458-460.
46. Khaliq Y., Zhanel G.G. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis 2003, 36:1404-1410.
47. Ozaras R., Mert A., Tahan V., et al. Ciprofloxacin and Achilles' tendon rupture: a causal relationship. Clin Rheumatol 2003, 22:500-501.
48. Vanek D., Saxena A., Boggs J.M. Fluoroquinolone therapy and Achilles tendon rupture. J Am Podiatr Med Assoc 2003, 93:333-335.
49. Kowatari K., Nakashima K., Ono A., Yoshihara M., Amano M., Toh S. Levofloxacin-induced bilateral Achilles tendon rupture: a case report and review of the literature. J Orthop Sci 2004, 9:186-190.
50. Mathis A.S., Chan V., Gryszkiewicz M., Adamson R.T., Friedman G.S. Levofloxacin-associated Achilles tendon rupture. Ann Pharmacother 2003, 37:1014-1017.
51. de La Red G., Mejía J.C., Cervera R., Lladó A., Mensa J., Font J. Bilateral Achilles tendinitis with spontaneous rupture induced by levofloxacin in a patient with systemic sclerosis. Clin Rheumatol 2003, 22:367-368.
52. Greene B.L. Physical therapist management of fluoroquinolone-induced Achilles tendinopathy. Phys Ther 2002, 82:1224-1231.
53. van der Linden P.D., Sturkenboom M.C., Herings R.M., Leufkens H.G., Stricker B.H. Fluoroquinolones and risk of Achilles tendon disorders: case-control study. BMJ 2002, 324:1306-1307.
54. Chhajed P.N., Plit M.L., Hopkins P.M., Malouf M.A., Glanville A.R. Achilles tendon disease in lung transplant recipients: association with ciprofloxacin. Eur Respir J 2002, 19:469-471.
55. Casparian J.M., Luchi M., Moffat R.E., Hinthorn D. Quinolones and tendon ruptures. South Med J 2000, 93:488-491.
56. Schwald N., Debray-Meignan S. Suspected role of ofloxacin in a case of arthalgia, myalgia, and multiple tendinopathy. Rev Rheum Engl Ed 1999, 66:419-421.
57. Harrell R.M. Fluoroquinolone-induced tendinopathy: what do we know?. South Med J 1999, 92:622-625.
58. McEwan S.R., Davey P.G. Ciprofloxacin and tenosynovitis. Lancet 1988, II:900.
59. Le Huec J.C., Schaeverbeke T., Chauveaux D., Rivel J., Dehais J., Le Rebeller A. Epicondylitis after treatment with fluoroquinolone antibiotics. J Bone Joint Surg Br 1995, 77:293-295.
60. Mouzopoulos G., Stamatakos M., Vasiliadis G., Skandalakis P. Rupture of adductor longus tendon due to ciprofloxacin. Acta Orthop Belg 2005, 71:743-745.
61. Beyer J., Schellong S. Bilateral plantar tendinitis during levofloxacin therapy. Br J Clin Pharmacol 2006, 61:609.
62. Karistinos A., Paulos L.E. "Ciprofloxacin-induced" bilateral rectus femoris tendon rupture. Clin J Sport Med 2007, 17:406-407.
63. Kayabas U., Yetkin F., Firat A.K., Ozcan H., Bayindir Y. Ciprofloxacin-induced urticaria and tenosynovitis: a case report. Chemotherapy 2008, 54:288-290.
64. Fraunfelder F.W., Fraunfelder F.T. Diplopia and fluoroquinolones. Ophthalmology 2009, 116:1814-1817.
65. van der Linden P.D., van de Lei J., Nab H.W., Knol A., Stricker B.H. Achilles tendinitis associated with fluoroquinolones. Br J Clin Pharmacol 1999, 48:433-437.
66. Pierfitte C., Royer R.J. Tendon disorders with fluoroquinolones. Therapie 1996, 51:419-420.
67. Wilton L.V., Pearce G.L., Mann R.D. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br J Clin Pharmacol 1996, 41:277-284.
68. van der Linden P.D., Sturkenboom M.C., Herings R.M., Leufkens H.M., Rowlands S., Stricker B.H. Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med 2003, 163:1801-1807.
69. Belavic J.M. Fluoroquinolone-induced tendinopathy. Nurse Pract 2009, 34:17-18.
70. Mont M.A., Mathur S.K., Frondoza C.G., Hungerford D.S. The effects of ciprofloxacin on human chondrocytes in cell culture. Infection 1996, 24:151-155.
71. Menschik M., Neumüller J., Steiner C.W., et al. Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro. Antimicrob Agents Chemother 1997, 41:2562-2565.
72. Sansone J.M., Wilsman N.J., Leiferman E.M., Conway J., Hutson P., Noonan K.J. The effect of fluoroquinolone antibiotics on growing cartilage in the lamb model. J Pediatr Orthop 2009, 29:189-195.
73. Multhaupt H.A., Alvarez J.C., Rafferty P.A., Warhol M.J., Lackman R.D. Fluoroquinolone's effect on growth of human chondrocytes and chondrosarcomas. In vitro and in vivo correlation. J Bone Joint Surg Am 2001, 83-A(Suppl 2):56-61.
74. Stahlmann R., Kühner S., Shakibaei M., Flores J., Vormann J., van Sickle D.C. Effects of magnesium deficiency on joint cartilage in immature beagle dogs: immunohistochemistry, electron microscopy, and mineral concentrations. Arch Toxicol 2000, 73:573-580.
75. Egerbacher M., Wolfesberger B., Gabler C. In vitro evidence for effects of magnesium supplementation on quinolone-treated horse and dog chondrocytes. Vet Pathol 2001, 38:143-148.
76. Huddleston P.M., Steckelberg J.M., Hanssen A.D., Rouse M.S., Bolander M.E., Patel R. Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am 2000, 82:161-173.
77. Perry A.C., Prpa B., Rouse M.S., et al. Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clin Orthop Relat Res 2003, (414):95-100.
78. O-Lee T., Stewart C.E., Seery L., Church C.A. Fluoroquinolone-induced arthralgia and myalgia in the treatment of sinusitis. Am J Rhinol 2005, 19:395-399.
79. Hernandez R., Edgerton L., Flake D., Groetsch S.M. Clinical inquiries. Is there much risk in using fluoroquinolones in children?. J Fam Pract 2008, 57:539-540.
80. Forsythe C.T., Ernst M.E. Do fluoroquinolones commonly cause arthropathy in children?. Can J Emerg Med 2007, 9:459-462.
81. Aricò M., Bossi G., Caselli D., et al. Long-term magnetic resonance survey of cartilage damage in leukemic children treated with fluoroquinolones. Pediatr Infect Dis J 1995, 14:713-714.
82. Chalumeau M., Tonnelier S., D'Athis P., et al. Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France. Pediatrics 2003, 111:e714-e719.
83. Danisovicová A., Brezina M., Belan S., et al. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey. Chemotherapy 1994, 40:209-214.
84. Chang H., Chung M.H., Kim J.H., Kim J.H. Pefloxacin-induced arthropathy in an adolescent with brain abscess. Scand J Infect Dis 1996, 28:641-643.
85. Baril L., Maisonobe T., Jasson-Molinier M., Haroche J., Bricaire F., Caumes E. Acute rhabdomyolysis during treatment with ofloxacin-a case report. Clin Infect Dis 1999, 29:1598-1599.
86. Guis S., Jouglard J., Kozak-Ribbens G., et al. Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment. J Rheumatol 2001, 28:1405-1406.
87. Guis S., Bendahan D., Kozak-Ribbens G., et al. Investigation of fluoroquinolone-induced myalgia using (31)P magnetic resonance spectroscopy and in vitro contracture tests. Arthritis Rheum 2002, 46:774-778.
88. Kumar S. Steroid-induced myopathy following a single oral dose of prednisolone. Neurol India 2003, 51:554-556.
89. Betters J.L., Long J.H., Howe K.S., et al. Nitric oxide reverses prednisolone-induced inactivation of muscle satellite cells. Muscle Nerve 2008, 37:203-209.
90. Inder W.J., Jang C., Obeyesekere V.R., Alford F.P. Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1: implications for steroid-induced myopathy. Clin Endocrinol (Oxf) 2010, 73:126-132.
91. Sawant R.D. Rhabdomyolysis due to an uncommon interaction of ciprofloxacin with simvastatin. Can J Clin Pharmacol 2009, 16:e78-e79.
92. Korzets A., Gafter U., Dicker D., Herman M., Ori Y. Levofloxacin and rhabdomyolysis in a renal transplant patient. Nephrol Dial Transplant 2006, 21:3304-3305.
93. Petitjeans F., Nadaud J., Perez J.P., et al. A case of rhabdomyolysis with fatal outcome after a treatment with levofloxacin. Eur J Clin Pharmacol 2003, 59:779-780.
94. Hsiao S.H., Chang C.M., Tsao C.J., Lee Y.Y., Hsu M.Y., Wu T.J. Acute rhabdomyolysis associated with ofloxacin/levofloxacin therapy. Ann Pharmacother 2005, 39:146-149.
95. George P., Das J., Pawar B., Badyal D. Gatifloxacin-induced rhabdomyolysis. J Postgrad Med 2008, 54:233-234.
96. Roberts J.R., Hudson J.A., Lindell K.K., Finger D.R. Serial sonographic evaluation of Achilles tendons in patients taking fluoroquinolone antibiotics. Hawaii Med J 2006, 65:112-114.
97. Arnaud M.J. Update on the assessment of magnesium status. Br J Nutr 2008, 99(Suppl 3):S24-S36.
98. Cohen J. A report of major improvement in a case of fluoroquinolone toxicity. MedicationSense E-Newsletter Accessed on October 9, 2009. http://www.medicationsense.com/articles/jan_dec_08/toxicity070508.html.
99. Lavalle M. Medical committee report. USA Weightlifting Magazine 2003, 22:7. 33.